How certain HBV RNAs affect the life cycle of the hepatitis B virus
Influence of integrant-derived HBV RNAs encoding the envelope proteins on HBV life cycle
This study is looking at how certain RNA molecules from the hepatitis B virus might help the virus stick around in the body, using samples from people with chronic hepatitis B, to find new ways to treat the infection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11012396 on NIH RePORTER |
What this research studies
This research investigates the role of integrant-derived HBV RNAs that encode envelope proteins in the life cycle of the hepatitis B virus (HBV). By analyzing liver and hepatocellular carcinoma (HCC) tissues from chronic HBV carriers, the study aims to understand how these RNAs contribute to HBV infection and persistence. The researchers will utilize techniques like RT-PCR to examine the accumulation and types of HBV RNAs present in various tissues, which could reveal new insights into HBV biology and potential treatment targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are chronic carriers of hepatitis B virus.
Not a fit: Patients who do not have chronic hepatitis B infection or those who have already achieved a sustained viral response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for chronic hepatitis B infection, potentially reducing the risk of liver cancer.
How similar studies have performed: While the role of HBV RNAs has been explored, this specific focus on integrant-derived RNAs and their impact on the HBV life cycle is relatively novel and has not been extensively tested.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Gudima, Severin O — University of Kansas Medical Center
- Study coordinator: Gudima, Severin O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.